Glioma stem cell signature predicts the prognosis and the response to tumor treating fields treatment.
Bo ChenXiaoxi ZhouLiting YangHongshu ZhouMing MengHao WuZhixiong LiuLiyang ZhangChuntao LiPublished in: CNS neuroscience & therapeutics (2022)
Our study constructed a GSC signature consisting of 11 GSC-specific genes and identified its prognostic value in gliomas. TTF is a promising therapeutic approach for patients with GSC-enriched glioma.